TG Therapeutics Inc (TGTX)

Payables turnover

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cost of revenue (ttm)	US$ in thousands	177,271	162,242	145,863	133,962	117,671	95,647	77,570	70,111	80,019	100,664	122,043	101,520	112,914	113,311	93,728	107,850	68,247	36,265	24,547	15,607
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

September 30, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $177,271K ÷ $—K
= —

The payables turnover ratio for TG Therapeutics Inc is unavailable as the data for accounts payable and cost of goods sold needed to calculate this ratio is missing for all the periods listed in the table. Without this information, it is not possible to analyze the efficiency of TG Therapeutics Inc in managing its accounts payable by evaluating how quickly the company pays its suppliers within a given period.